WebMD’s Pill Identifier can help you put a name to an unknown medication. It identifies prescription and over-the-counter (OTC) meds that you take in solid form by mouth, like tablets and capsules.

The drugmaker responsible for bringing the controversial abortion pill to the U.S. is now pursuing a new use that could widen ...

As a daily pill-taker, I’ve learned that the phrase “Out of sight, out of mind” holds all too true when it comes to staying on top of my medications. A pill case that looks and feels nice ...

The drug manufacturer has developed a pill that could bring about weight ... “A single molecule that targets both amylin and ...

In May, a senior health ministry official told parliament it was finally set to approve an abortion pill manufactured by British pharmaceutical company Linepharma International. But he also said ...

Elon Musk offered $54.20 per share to acquire Twitter, prompting a "poison pill" defense. Poison pill allows shareholders to buy shares cheaply, diluting the takeover bidder's stake. If a company ...

The NHS will start offering an "improved" stop smoking pill to tens of thousands of people in England who want to quit cigarettes. Varenicline, a daily tablet given over a few months, is as ...

The need for male enhancement tablets has dramatically increased recently, as more and more men are looking to enhance their sexual capabilities and assurance. These pills are formulated to ...

Novo Nordisk’sNOVO.B-1.06%decrease; red down pointing triangle once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up to 14% ...

While apple cider vinegar in liquid form may have health benefits, little research exists on these effects in pill form ... The researchers found that the tablets may not be as effective as ...

Wegovy Maker Novo Nordisk's Oral Diabetes Pill Cuts Heart Attacks, Stroke Events By 14% On Monday, Novo Nordisk A/S (NYSE:NVO) released the headline results from the SOUL Phase 3 cardiovascular ...

The SOUL trial showed a 14% reduction in major cardiovascular events (MACE) for oral semaglutide. Novo Nordisk plans to seek regulatory approval for Rybelsus label expansion by late 2024 or early ...